The following bibliography has been generated by bringing together all references provided by our content partners. There may be duplication.


  • Available from:
  • Works Cited:
  • 2. Truong, DD et al. Current clinical applications of Botulinum toxin. Current Pharmaceutical Design. 15.31 (2009): 3671-80.
  • 3. Ward, Anthony B., and Michael P. Barnes. Clinical uses of botulinum toxins.Vol. 1. Cambridge, UK: Cambridge University Press, 2007. 4-6.
  • 4. Munchau A and Bhatia KP. Uses of botulinum toxin in medicine today. British Medical Journal. 320.7228 (2000): 161-65.
  • 5. Leclair, Daniel et al. Distribution of Clostridium botulinum Type E strains in Nunavik, Northern Quebec, Canada..Applied and Environmental Microbiology. 79.2 (2013): 646-54.
  • Arnon, Stephen et al. Botulinum toxin as a biological weapon. l,. 2001.The Journal of the American Medical Association. 285.8 (2001): 1059-70.
  • Available From:
  • Available from:
  • Available from:
  • Bergey. 1923. IJSB Vol.30 pp.278
  • Kopera, D. 2011. Botulinum toxin historical aspects: from food poisoning to pharmaceutical. International Journal of Dermatology 50: 976-980.
  • Peck, M.W., S.C. Stringer, and A.T. Carter. 2011. Clostridium botulinum in the post-genomic era. Food Microbiology 28: 183-191.
  • Shimura J., Hiraki K. & Garrity G.M. (eds) (2013). BIOS: Bacteriology Insight Orienting System (version Dec 2006). In: Species 2000 & ITIS Catalogue of Life, 11th March 2013 (Roskov Y., Kunze T., Paglinawan L., Orrell T., Nicolson D., Culham A., Bailly N., Kirk P., Bourgoin T., Baillargeon G., Hernandez F., De Wever A., eds). Digital resource at Species 2000: Reading, UK.


EOL content is automatically assembled from many different content providers. As a result, from time to time you may find pages on EOL that are confusing.

To request an improvement, please leave a comment on the page. Thank you!